REZN.F Stock Overview
Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
The Hash Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.001 |
52 Week High | CA$0.016 |
52 Week Low | CA$0.0002 |
Beta | 0.81 |
11 Month Change | 233.33% |
3 Month Change | -81.13% |
1 Year Change | -50.98% |
33 Year Change | -95.94% |
5 Year Change | n/a |
Change since IPO | -95.95% |
Recent News & Updates
Recent updates
Shareholder Returns
REZN.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 100.0% | -1.4% | -0.7% |
1Y | -51.0% | 20.6% | 32.5% |
Return vs Industry: REZN.F underperformed the US Pharmaceuticals industry which returned 20.6% over the past year.
Return vs Market: REZN.F underperformed the US Market which returned 32.5% over the past year.
Price Volatility
REZN.F volatility | |
---|---|
REZN.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.5% |
Market Average Movement | 6.4% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: REZN.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine REZN.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | n/a | Chris Savoie | www.thehashcorporation.com |
The Hash Corporation focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada. It applies its separation and curing techniques to produce a suite of cannabis resin products, which are natural and free of additives. The company was formerly known as Senternet Phi Gamma Inc. and changed its name to The Hash Corporation in July 2019.
The Hash Corporation Fundamentals Summary
REZN.F fundamental statistics | |
---|---|
Market cap | US$1.03m |
Earnings (TTM) | -US$198.28k |
Revenue (TTM) | US$330.65k |
3.1x
P/S Ratio-5.2x
P/E RatioIs REZN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
REZN.F income statement (TTM) | |
---|---|
Revenue | CA$448.97k |
Cost of Revenue | CA$247.78k |
Gross Profit | CA$201.19k |
Other Expenses | CA$470.42k |
Earnings | -CA$269.23k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.00096 |
Gross Margin | 44.81% |
Net Profit Margin | -59.97% |
Debt/Equity Ratio | -51.1% |
How did REZN.F perform over the long term?
See historical performance and comparison